Table 4.
Relationship between laboratory findings, coronary artery dilatation, and ocular involvement in Kawasaki disease patients.
| Characteristic | Conjunctivitis (+) group (n = 23) |
Conjunctivitis (−) group (n = 13) |
P value* | Uveitis (+) group (n = 13) |
Uveitis (−) group (n = 23) |
P value* |
|---|---|---|---|---|---|---|
| WBC (×109/L) | 13.76 ± 4.33 | 14.24 ± 11.19 | 0.86 | 16.12 ± 8.05 | 12.69 ± 7.59 | 0.21 |
| Platelets (×109/L) | 474 ± 180.16 | 564.62 ± 271.97 | 0.24 | 496.15 ± 227.36 | 513.17 ± 218.09 | 0.82 |
| Neutrophils (%) | 60.66 ± 18.32 | 51.63 ± 16.77 | 0.15 | 77.03 ± 6.24 | 46.30 ± 11.96 | 0.001 |
| AST (IU/l) | 36.95 ± 22.81 | 39.23 ± 16.27 | 0.75 | 42.23 ± 28.21 | 35.26 ± 14.65 | 0.33 |
| ALT (IU/l) | 44.60 ± 37.89 | 26.76 ± 18.75 | 0.12 | 51.15 ± 46.11 | 30.82 ± 20.78 | 0.07 |
| ESR (mm/hr) | 64.78 ± 26.02 | 55.23 ± 41.40 | 0.31 | 57.23 ± 19.52 | 63.65 ± 30.92 | 0.505 |
| CRP (mg/l) | 44.17 ± 29.28 | 24.76 ± 30.10 | 0.14 | 77.84 ± 31.05 | 14.17 ± 17.15 | 0.001 |
| Coronary artery dilatation | 7 (30.4%) | 3 (23%) | 0.06 | 8 (61.5%) | 2 (8.6%) | 0.001 |
WBC white blood cell, AST aspartate aminotransferase, ALT alanine aminotransferase, ESR erythrocyte sedimentation rate, CRP C-reactive protein
*P < 0.05 indicates statistically significant differences